Fate Therapeutics Inc. buy Mizuho
Start price
20.11.23
/
50%
€2.37
Target price
20.11.24
€7.31
Performance (%)
-14.58%
End price
21.11.24
€2.03
Summary
This prediction ended on 21.11.24 with a price of €2.03. The prediction for Fate Therapeutics Inc. disappointed with a performance of -14.58%. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | 4.829% | 4.829% | 20.189% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Mizuho for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Mizuho from $12.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten